Beneficient Schedules Special Shareholder Meeting for Oct 2
Ticker: BENFW · Form: DEF 14A · Filed: Sep 20, 2024 · CIK: 1775734
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, capital-increase, corporate-governance
Related Tickers: BENF
TL;DR
BENF meeting Oct 2 to vote on more shares & board changes - big dilution risk?
AI Summary
Beneficient (NASDAQ: BENF) is holding a Special Meeting of Stockholders on October 2, 2024, to vote on several proposals. Key proposals include the election of directors, ratification of the appointment of their independent registered public accounting firm, and approval of an amendment to the company's certificate of incorporation to increase the authorized number of shares of common stock from 1,000,000,000 to 5,000,000,000. The company is headquartered in Dallas, Texas.
Why It Matters
This meeting is crucial for shareholders as it involves decisions on corporate governance, financial oversight, and significant changes to the company's capital structure, which could impact future stock value and dilution.
Risk Assessment
Risk Level: medium — The proposed increase in authorized shares from 1 billion to 5 billion represents a significant potential for dilution, which could negatively impact existing shareholders.
Key Numbers
- 1B to 5B — Authorized Shares Increase (Proposal to increase the number of authorized shares of common stock.)
- Oct 2, 2024 — Meeting Date (Date of the Special Meeting of Stockholders.)
Key Players & Entities
- Beneficient (company) — Registrant
- October 2, 2024 (date) — Special Meeting Date
- 1,000,000,000 (dollar_amount) — Current authorized shares
- 5,000,000,000 (dollar_amount) — Proposed authorized shares
- NASDAQ: BENF (company) — Stock Ticker
- Dallas, Texas (location) — Company Headquarters
FAQ
What is the primary purpose of the Special Meeting of Stockholders?
The primary purpose is to vote on several proposals, including the election of directors, ratification of the independent registered public accounting firm, and an amendment to increase the authorized number of shares of common stock.
What is the proposed change to Beneficient's authorized shares?
The company proposes to amend its certificate of incorporation to increase the authorized number of shares of common stock from 1,000,000,000 to 5,000,000,000.
When is the Special Meeting of Stockholders scheduled to take place?
The Special Meeting of Stockholders is scheduled for October 2, 2024.
Who is Beneficient's independent registered public accounting firm?
The filing indicates that the ratification of the appointment of their independent registered public accounting firm is one of the proposals to be voted on at the meeting, but the name of the firm is not explicitly stated in this excerpt.
What is the potential impact of increasing authorized shares?
Increasing authorized shares can allow for future stock issuances, which could be used for acquisitions, financing, or employee compensation, but also carries the risk of diluting existing shareholders' ownership percentage and earnings per share.
Filing Stats: 4,610 words · 18 min read · ~15 pages · Grade level 12.9 · Accepted 2024-09-20 06:30:23
Key Financial Figures
- $0.001 — ares of Class A common stock, par value $0.001 per share (the “Class A Common St
Filing Documents
- formdef14a.htm (DEF 14A) — 258KB
- formdef14a_001.jpg (GRAPHIC) — 4KB
- formdef14a_002.jpg (GRAPHIC) — 3674KB
- formdef14a_003.jpg (GRAPHIC) — 2863KB
- formdef14a_004.jpg (GRAPHIC) — 1373KB
- proxy_001.jpg (GRAPHIC) — 371KB
- proxy_002.jpg (GRAPHIC) — 386KB
- 0001493152-24-037242.txt ( ) — 12186KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 11 REQUIREMENTS FOR ADVANCE NOTIFICATION OF NOMINATIONS AND STOCKHOLDER PROPOSALS 14 OTHER MATTERS 14 WHERE YOU CAN FIND ADDITIONAL INFORMATION 14 ANNEX A – FORM OF AMENDMENT TO ARTICLES OF INCORPORATION A-1 Forward-Looking This proxy statement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this proxy statement that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the Company’s expectations regarding its ordinary course liquidity transactions and ability to raise additional capital, including pursuant to its Standby Equity Purchase Agreement, by and between the Company and YA II PN, Ltd., dated June 27, 2023, our expectations regarding future issuances of our shares, the potential dilutive effects of any future issuances, and the impact of any future issuances on prevailing market prices for our Class A Common Stock, par value $0.001 per share. These statements are based on management’s current assumptions and are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including that the Authorized Shares Proposal may not be approved by the Company’s stockholders. For other important factors that could cause actual results to differ materially from the forward-looking statements in this proxy statement, please see the risks and uncertainties identified under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended March 31, 2024, as updated by the Company’s Quarte